Good news! EU approves @GileadSciences' new injection for preventing HIV #Lenacapavir. But it's unaffordable—despite research showing it could cost nearly 1000x less. Gilead can enable affordability by allowing generic production across the world.
https://t.co/MPFibZ5UOs
Public financing for health is an investment, not a cost. When governments #InvestInHealth, lives are saved, productivity rises, and economies grow.
See how the @GlobalFund’s co-financing model will help #Save23MillionLives: https://t.co/uQlpcaKhN8
🌍 #OneWorldOneFight
Historic milestone: For the first time, @GlobalFund has procured a first-line HIV treatment manufactured in Africa - antiretroviral medicines (ARVs), sourced from a Kenyan pharmaceutical company & delivered to Mozambique.
Strengthening supply security & expanding access across the continent.
https://t.co/OlfhxejyzI
Millions will die if US aid for HIV is stopped immediately.
Yet, we are on the cusp of a prevention revolution to end all new infections. We urge the USA admin to remain in the global partnership to end AIDS.
https://t.co/itNE9ZHYzu
Without US foreign aid, projections show by 2029:
✔️ 8.7 million people newly infected with HIV
✔️ 6.3 million AIDS-related deaths
✔️ an additional 3.4 million children made orphans
Sharing my interview with @AP, on the US funding pause #endAIDS2030
https://t.co/i6cE8DqXEt
#ParisAgreement was adopted by all nations in 2015 because they recognized the immense harm that #ClimateChange is causing & the enormous opportunity that #ClimateAction presents.
The collective efforts have made a difference, but we need to go much further and faster together.